Incyte INCY Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 371.1%-0.1pp | 371.2%-0.4pp | 371.1%-1.0pp | 371%-1.5pp | 371.2%-1.5pp | |
| Operating margin | 116.1%+112pp | 90%+71.2pp | 62%+27.8pp | 29.9%-19.5pp | 4.5%-56.6pp | |
| Net margin | 95.4%+90.9pp | 69.2%+45.3pp | 44.9%+5.7pp | 21%-29.2pp | 4.6%-53.6pp | |
| EBITDA margin | 123.5%+110pp | 97.7%+70.1pp | 70%+26.9pp | 38.2%-20.2pp | 13.1%-56.9pp | |
| Free cash flow margin | 103.3%+86.2pp | 83.6%+53.4pp | 64.1%+28.4pp | 40.4%-9.9pp | 17.1%-55.6pp | |
| Returns | ||||||
| Return on equity | 115.4%+111pp | 85%+65.8pp | 55.9%+25.0pp | 26.3%-13.1pp | 4.5%-40.7pp | |
| Return on assets | 80.2%+77.0pp | 58.7%+44.2pp | 38.4%+15.1pp | 18%-11.9pp | 3.2%-31.3pp | |
| Return on invested capital | 216.3%+211pp | 155.3%+128pp | 97.6%+46.6pp | 42.6%-29.9pp | 5.1%-83.8pp | |
| Efficiency | ||||||
| Asset turnover | 3.4×+0.6× | 3.2×+0.5× | 3.1×+0.5× | 3×+0.5× | 2.8×+0.4× | |
| Inventory turnover | 4.3×-0.5× | 4.2×-1.0× | 4.2×-1.6× | 4.5×-2.4× | 4.8×-3.4× | |
| Liquidity | ||||||
| Current ratio | 13×+5.2× | 11.4×+2.2× | 10.1×-1.0× | 8.7×-4.3× | 7.8×-7.1× | |
| Quick ratio | 12×+5.0× | 10.4×+2.0× | 9.1×-1.2× | 7.8×-4.6× | 7×-7.3× | |
| Cash ratio | 7.7×+4.0× | 6.5×+1.5× | 5.5×-1.1× | 4.6×-4.0× | 3.8×-6.9× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -6.9×+56.1× | -12.1×+48.1× | -21×+32.9× | -55.3×-31.8× | -63.1×-42.7× | |
| Interest coverage | 2,450.3×+2,367× | 1,830.6×+1,544× | 1,233.6×+730× | 560.1×-172× | 82.9×-818× | |
| Per Share | ||||||
| Book value per share | $97.01+49.7% | $88.33+26.1% | $78.96+3.0% | $72.06-12.4% | $64.81-27.6% | |
| Valuation | ||||||
| Market capitalization | $68.04B+28.3% | $61.03B+12.8% | $54.94B+0.1% | $52.8B-1.2% | $53.05B-1.3% | |
| Enterprise value | $57.25B+21.0% | $51.76B+10.2% | $47.09B+1.9% | $46.1B+7.7% | $47.31B+15.4% | |
| Price / earnings | 57.4×-1,485× | 595.3×-414× | 988.2×+364× | 1,418.2×+1,207× | 1,542.7×+1,434× | |
| Price / sales | 13.6×+0.8× | 12.8×-0.8× | 12.1×-2.1× | 12.2×-2.1× | 12.9×-1.9× | |
| Price / book | 13.8×-2.3× | 13.7×-1.6× | 13.8×-0.4× | 14.8×+2.6× | 16.1×+5.5× | |
| EV / EBITDA | 37.1×-572× | 65.3×-519× | 132.7×-390× | 495.2×+328× | 609.2×+543× | |
| EV / sales | 11.5×0.0× | 10.8×-0.9× | 10.4×-1.6× | 10.7×-0.8× | 11.5×+0.2× | |
| Free cash flow yield | 30.3%+24.4pp | 25.5%+16.4pp | 20.7%+10.6pp | 13.8%-0.3pp | 5.9%-13.9pp | |
| Earnings yield | 28%+26.6pp | 20.5%+13.5pp | 14.1%+3.1pp | 7.2%-6.9pp | 1.4%-14.6pp | |
| PEG ratio | 0×— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Incyte's profit margins?
- Incyte (INCY) runs a 92.5% gross margin and a 30.0% operating margin, with a 26.7% net margin.
- Where do Incyte's ratios come from?
- Every ratio is computed from Incyte's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
